Glenmark Pharmaceuticals has launched a triple-fixed-dose combination drug called Zita for the treatment of Type 2 diabetes. The drug, which combines Teneligliptin, Dapagliflozin, and Metformin, is priced at Rs 14 per tablet and aims to improve glycemic control in diabetic patients. The medication is expected to lower the daily cost of therapy by 30%, making it more affordable for patients.
Glenmark Pharma and OMRON Healthcare India team up to combat hypertension ignorance among young adults in India laosnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from laosnews.net Daily Mail and Mail on Sunday newspapers.
Get latest articles and stories on Business at LatestLY. Mumbai (Maharashtra) [India], August 3: Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led, global pharmaceutical company has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions for cardiovascular disease management, to raise awareness on measuring blood pressure at home from the age of 18. Business News | Glenmark Pharma and OMRON Healthcare India Team Up to Combat Hypertension Ignorance Among Young Adults in India.
Glenmark Pharmaceuticals Ltd on Thursday said it has slashed the price of breast cancer drug Trastuzumab by bringing its brand Trumab at Rs 15,749 for a 440 mg vial from Rs 54,000 earlier.